TARGET AUDIENCE
The target audience for this educational activity is pediatric endocrinologists, pediatricians, neonatologists, and other pediatric specialists.
 

PROGRAM DESCRIPTION
Improving Care for Patients with Turner Syndrome will focus on the areas in which improvements in patient management are most urgently needed: expediting the diagnosis of Turner syndrome, ensuring that newly diagnosed patients receive necessary screenings and that established patients receive necessary monitoring at recommended intervals, and making sure that patients receive hormone replacement therapy (growth hormone and estrogen) using the right agent, beginning at the right time, at the most appropriate, individualized doses, and for the optimal duration.

Our faculty will review the new international Turner syndrome clinical practice guidelines. The presenters will summarize key recommendations contained in the 2017 guidelines and highlight the ways in which recommendations have changed since 2007.

There is no fee to participate in this symposium.
 

LEARNING OBJECTIVES
After attending this symposium, the participant should be better able to:

•   Adopt best practices for expediting the diagnosis of Turner syndrome
•   Incorporate into practice current international guidance for screening newly diagnosed
    patients for Turner syndrome-related conditions and for monitoring established patients at
    recommended intervals
•   Optimize patient outcomes by ensuring that individuals with Turner syndrome receive the
    most appropriate regimens of growth hormone therapy and estrogen replacement therapy
 

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of American Academy of CME, Inc. and Scherer Clinical Communications. American Academy of CME, Inc. is accredited by the ACCME to provide continuing medical education for physicians.

American Academy of CME, Inc. designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 
DISCLOSURE
According to the disclosure policy of the Academy, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any significant relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed. If a conflict is identified, it is the responsibility of the Academy to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

The opinions expressed in this educational activity are those of the faculty, and do not represent those of Academy or Scherer Clinical Communications. This activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically and draw conclusions only after careful consideration of all available scientific information.
 

 
PRELIMINARY AGENDA
 
Welcome
Philippe F. Backeljauw, MD- Chair
 
Early Identification of Turner Syndrome- Diagnostic and Genetic Aspects
Philippe F. Backeljauw, MD

Growth Hormone, Estrogen, and Fertility Issues in Turner Syndrome
Nelly Mauras, MD

Evaluation and Monitoring of Comorbidities Found with Turner Syndrome
Claus Gravholt, MD

Panel Discussion and Closing Remarks

 
FACULTY

Philippe F. Backeljauw, MD
Director, Cincinnati Center for Pediatric and Adult Turner Syndrome Care
Fellowship Program Director, Division of Endocrinology
Professor of Clinical Pediatrics
Cincinnati Children’s Hospital Medical Center
University of Cincinnati College of Medicine
Cincinnati, OH

Nelly Mauras, MD
Chief, Division of Endocrinology, Diabetes & Metabolism
Nemours Children’s Health System
Professor of Pediatrics
Mayo College of Medicine
Jacksonville, FL
 
Claus Hojbjerg Gravholt, MD, PhD, DMSc
Professor
Department of Endocrinology and Internal Medicine (MEA) and
Department of Molecular Medicine (MOMA)
Aarhus University Hospital
Aarhus, Denmark